Literature DB >> 20682190

Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease.

Garth R Swanson1, Shahriar Sedghi, Ashkan Farhadi, Ali Keshavarzian.   

Abstract

Alcohol consumption is a potential trigger for flare in inflammatory bowel disease (IBD) flare because of alcohol's pro-oxidant effects and its deleterious effects on gut barrier function. The association with alcohol consumption and IBD flare is unclear. To test this hypothesis, we evaluated the pattern of alcohol consumption and its self-reported effect on gastrointestinal (GI) symptoms in patients with IBD. We recruited 129 consecutive patients: 52 patients with Crohn's disease, 38 patients with ulcerative colitis, and 39 patients with irritable bowel syndrome (IBS). All the participants completed a validated questionnaire on disease activity (the Crohn's disease activity index or ulcerative colitis clinical activity index, respectively) validated questionnaires to quantify alcohol consumption by National Institute of Alcohol Abuse and Alcoholism criteria, and two structured questionnaires we designed to access patients' perception of the effect of alcohol on their GI symptoms and on overall GI symptom severity. The pattern of current, light, moderate, and heavy alcohol consumption in inactive IBD was similar to the general U.S. population. Specifically, of the 90 inactive IBD patients, 56 (62%) were current drinkers, compared with 61% in the general U.S. population. Of current drinkers, 75% of IBD (N=42) and 43% of IBS (N=9) reported a worsening of GI symptoms with alcohol consumption (P=.01); however, overall GI symptom severity did not differ when compared with quantity of alcohol consumed. Patients with inactive IBD drink alcohol in quantities similar to the general population. Current drinkers with inactive IBD are more likely to report worsening of GI symptoms with alcohol than current drinkers with IBS. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20682190      PMCID: PMC3708696          DOI: 10.1016/j.alcohol.2009.10.019

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  24 in total

Review 1.  A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.

Authors:  William J Sandborn; Brian G Feagan; Stephen B Hanauer; Herbert Lochs; Robert Löfberg; Robert Modigliani; Daniel H Present; Paul Rutgeerts; Jurgen Schölmerich; Eduard F Stange; Lloyd R Sutherland
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

2.  Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study.

Authors:  S L Jowett; C J Seal; M S Pearce; E Phillips; W Gregory; J R Barton; M R Welfare
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

3.  GSRS--a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease.

Authors:  J Svedlund; I Sjödin; G Dotevall
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

4.  Smoking habits and recurrence in Crohn's disease.

Authors:  M Cottone; M Rosselli; A Orlando; L Oliva; A Puleo; M Cappello; M Traina; F Tonelli; L Pagliaro
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

5.  Smoking cessation and the course of Crohn's disease: an intervention study.

Authors:  J Cosnes; L Beaugerie; F Carbonnel; J P Gendre
Journal:  Gastroenterology       Date:  2001-04       Impact factor: 22.682

6.  Diet as a risk factor for the development of ulcerative colitis.

Authors:  B J Geerling; P C Dagnelie; A Badart-Smook; M G Russel; R W Stockbrügger; R J Brummer
Journal:  Am J Gastroenterol       Date:  2000-04       Impact factor: 10.864

7.  Acute alcohol activates STAT3, AP-1, and Sp-1 transcription factors via the family of Src kinases to promote IL-10 production in human monocytes.

Authors:  Oxana Norkina; Angela Dolganiuc; Taryn Shapiro; Karen Kodys; Pranoti Mandrekar; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2007-06-15       Impact factor: 4.962

8.  Inhibition of myeloid dendritic cell accessory cell function and induction of T cell anergy by alcohol correlates with decreased IL-12 production.

Authors:  Pranoti Mandrekar; Donna Catalano; Angela Dolganiuc; Karen Kodys; Gyongyi Szabo
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

9.  Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life.

Authors:  F Pace; P Molteni; S Bollani; P Sarzi-Puttini; R Stockbrügger; G Bianchi Porro; D A Drossman
Journal:  Scand J Gastroenterol       Date:  2003-10       Impact factor: 2.423

10.  Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients.

Authors:  A Khoruts; L Stahnke; C J McClain; G Logan; J I Allen
Journal:  Hepatology       Date:  1991-02       Impact factor: 17.425

View more
  37 in total

1.  Risk factors for inflammatory bowel disease: A prospective multi-center study.

Authors:  Anjali D Amarapurkar; Deepak N Amarapurkar; Pravin Rathi; Prabha Sawant; Nikhil Patel; Praful Kamani; Krishnakant Rawal; Rajiv Baijal; Ameya Sonawane; Nitin Narawane; Samrat Kolekar; Naveen Totla
Journal:  Indian J Gastroenterol       Date:  2018-07-09

Review 2.  Summary of the 2018 Alcohol and Immunology Research Interest Group (AIRIG) meeting.

Authors:  Paulius V Kuprys; Hidekazu Tsukamoto; Bin Gao; Lin Jia; Jacob McGowan; Craig M Coopersmith; Maria Camargo Moreno; Holly Hulsebus; Avtar S Meena; Flavia M Souza-Smith; Philip Roper; Michelle T Foster; S Vamsee Raju; S Alex Marshall; Mayumi Fujita; Brenda J Curtis; Todd A Wyatt; Pranoti Mandrekar; Elizabeth J Kovacs; Mashkoor A Choudhry
Journal:  Alcohol       Date:  2018-08-24       Impact factor: 2.405

3.  Multicenter case-control study of the risk factors for ulcerative colitis in China.

Authors:  Yu-Fang Wang; Qin Ou-Yang; Bing Xia; Li-Na Liu; Fang Gu; Kai-Fang Zhou; Qiao Mei; Rui-Hua Shi; Zhi-Hua Ran; Xiao-Di Wang; Pin-Jin Hu; Kai-Chun Wu; Xin-Guang Liu; Ying-Lei Miao; Ying Han; Xiao-Ping Wu; Guo-Bing He; Jie Zhong; Guan-Jian Liu
Journal:  World J Gastroenterol       Date:  2013-03-21       Impact factor: 5.742

4.  Evidence-based clinical practice guidelines for inflammatory bowel disease.

Authors:  Katsuyoshi Matsuoka; Taku Kobayashi; Fumiaki Ueno; Toshiyuki Matsui; Fumihito Hirai; Nagamu Inoue; Jun Kato; Kenji Kobayashi; Kiyonori Kobayashi; Kazutaka Koganei; Reiko Kunisaki; Satoshi Motoya; Masakazu Nagahori; Hiroshi Nakase; Fumio Omata; Masayuki Saruta; Toshiaki Watanabe; Toshiaki Tanaka; Takanori Kanai; Yoshinori Noguchi; Ken-Ichi Takahashi; Kenji Watanabe; Toshifumi Hibi; Yasuo Suzuki; Mamoru Watanabe; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2018-02-10       Impact factor: 7.527

Review 5.  Infertility in men with inflammatory bowel disease.

Authors:  Takeshi Shin; Hiroshi Okada
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-08-06

6.  Summary of the 2016 Alcohol and Immunology Research Interest Group (AIRIG) meeting.

Authors:  Lisbeth A Boule; Cynthia Ju; Marisela Agudelo; Tiyash Parira; Abigail Cannon; Booker Davis; Jonathan Eby; Gail Cresci; Derrick R Samuelson; Pradeep Shukla; Waddah A Alrefai; Suhas Sureshchandra; Subhash C Pandey; Bernd Schnabl; Brenda J Curtis; Todd A Wyatt; Mashkoor A Choudhry; Elizabeth J Kovacs
Journal:  Alcohol       Date:  2017-09-23       Impact factor: 2.405

7.  Relationship between patterns of alcohol consumption and gastrointestinal symptoms among patients with irritable bowel syndrome.

Authors:  Kerryn W Reding; Kevin C Cain; Monica E Jarrett; Margaret D Eugenio; Margaret M Heitkemper
Journal:  Am J Gastroenterol       Date:  2013-01-08       Impact factor: 10.864

8.  Is moderate red wine consumption safe in inactive inflammatory bowel disease?

Authors:  Garth R Swanson; Vanessa Tieu; Maliha Shaikh; Chris Forsyth; Ali Keshavarzian
Journal:  Digestion       Date:  2011-08-26       Impact factor: 3.216

Review 9.  IL-1 and CD40/CD40L platelet complex: elements of induction of Crohn's disease and new therapeutic targets.

Authors:  Doha Anka Idrissi; Nezha Senhaji; Asmae Aouiss; Loubna Khalki; Youssef Tijani; Nabil Zaid; Fatima Zahra Marhoume; Abdallah Naya; Mounia Oudghiri; Mostafa Kabine; Younes Zaid
Journal:  Arch Pharm Res       Date:  2021-01-04       Impact factor: 4.946

10.  Alcohol enhances symptoms and propensity for infection in inflammatory bowel disease patients and a murine model of DSS-induced colitis.

Authors:  Abigail R Cannon; Paulius V Kuprys; Adrienne N Cobb; Xianzhong Ding; Anai N Kothari; Paul C Kuo; Joshua M Eberhardt; Adam M Hammer; Niya L Morris; Xiaoling Li; Mashkoor A Choudhry
Journal:  J Leukoc Biol       Date:  2018-05-18       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.